Stryker Hip Replacement
Ohio Stryker Hip Replacement Lawyers
On July 6, 2012, Stryker Orthopaedics recalled two of its hip implant products. The voluntary recall was prompted by the potential for fretting and/or corrosion at or near the modular-neck junction and high early failure rate. The Stryker Rejuvenate hip implant was previously recalled in Canada in May 2012.
Stryker Corp. is a Kalamazoo, Michigan-based company. In the first quarter of 2012, Stryker reported sales of hip implant products totaling $312 million.
The recalled products include the Rejuvenate Modular and ABG II modular-neck hip stems. While the Stryker Rejuvenate is not a metal-on-metal hip device, it does have some metal-on-metal components that can result in the development of metallosis in some patients. Metallosis can lead to bone damage, pain, tissue necrosis, allergic reactions, elevated levels of metal – especially cobalt and immunological complications.
The Rejuvenate and ABG products were first marketed in 2009 and were promoted as providing orthopedic surgeons with the ability to customize the implants to fit the individual patient’s anatomy, resulting in a better fit and longer implant life.
In November 2013, a partial settlement was reached in cases involving the DePuy ASR hip implant. Many of our clients will benefit from this settlement. Our commitment to helping patients injured by defective medical devices of all kinds is stronger than ever. Read more about the DePuy settlement in our blog post.